RIAD, Abanoub, Holger SCHÜNEMANN, Sameh ATTIA, Tina POKLEPOVIĆ PERIČIĆ, Marija Franka ŽULJEVIĆ, Mikk JÜRISSON, Ruth KALDA, Katrin LANG, Sudhakar MORANKAR, Elias Ali YESUF, Mohamed MEKHEMAR, Anthony DANSO-APPIAH, Ahmad SOFI-MAHMUDI, Giordano PÉREZ-GAXIOLA, Arkadiusz DZIEDZIC, João APÓSTOLO, Daniela CARDOSO, Janja MARC, Mayte MORENO-CASBAS, Charles Shey WIYSONGE, Amir QASEEM, Anna GRYSCHEK, Ivana TADIĆ, Mohammad Salman HUSSAIN, Mohammed Ahmed KHAN, Jitka KLUGAROVÁ, Andrea POKORNÁ, Michal KOŠČÍK and Miloslav KLUGAR. COVID-19 Vaccines Safety Tracking (CoVaST): Protocol of a Multi-Center Prospective Cohort Study for Active Surveillance of COVID-19 Vaccines’ Side Effects. International Journal of Environmental Research and Public Health. Basel: MDPI, 2021, vol. 18, No 15, p. 1-10. ISSN 1660-4601. Available from: https://dx.doi.org/10.3390/ijerph18157859.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name COVID-19 Vaccines Safety Tracking (CoVaST): Protocol of a Multi-Center Prospective Cohort Study for Active Surveillance of COVID-19 Vaccines’ Side Effects
Authors RIAD, Abanoub (818 Egypt, guarantor, belonging to the institution), Holger SCHÜNEMANN, Sameh ATTIA, Tina POKLEPOVIĆ PERIČIĆ, Marija Franka ŽULJEVIĆ, Mikk JÜRISSON, Ruth KALDA, Katrin LANG, Sudhakar MORANKAR, Elias Ali YESUF, Mohamed MEKHEMAR, Anthony DANSO-APPIAH, Ahmad SOFI-MAHMUDI, Giordano PÉREZ-GAXIOLA, Arkadiusz DZIEDZIC, João APÓSTOLO, Daniela CARDOSO, Janja MARC, Mayte MORENO-CASBAS, Charles Shey WIYSONGE, Amir QASEEM, Anna GRYSCHEK, Ivana TADIĆ, Mohammad Salman HUSSAIN (356 India, belonging to the institution), Mohammed Ahmed KHAN, Jitka KLUGAROVÁ (203 Czech Republic, belonging to the institution), Andrea POKORNÁ (203 Czech Republic, belonging to the institution), Michal KOŠČÍK (203 Czech Republic, belonging to the institution) and Miloslav KLUGAR (203 Czech Republic, belonging to the institution).
Edition International Journal of Environmental Research and Public Health, Basel, MDPI, 2021, 1660-4601.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30304 Public and environmental health
Country of publisher Switzerland
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 4.614
RIV identification code RIV/00216224:14110/21:00122061
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.3390/ijerph18157859
UT WoS 000681945000001
Keywords in English cohort studies; cross-sectional studies; COVID-19; drug-related side effects and adverse reactions; health personnel; mass vaccination; prevalence
Tags 14110516, 14110525, 14110611, 14119612, 14119613, rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 12/12/2022 13:40.
Abstract
Background: Coronavirus disease (COVID-19) vaccine-related side effects have a determinant role in the public decision regarding vaccination. Therefore, this study has been designed to actively monitor the safety and effectiveness of COVID-19 vaccines globally. Methods: A multi-country, three-phase study including a cross-sectional survey to test for the short-term side effects of COVID-19 vaccines among target population groups. In the second phase, we will monitor the booster doses’ side effects, while in the third phase, the long-term safety and effectiveness will be investigated. A validated, self-administered questionnaire will be used to collect data from the target population; Results: The study protocol has been registered at ClinicalTrials.gov, with the identifier NCT04834869. Conclusions: CoVaST is the first independent study aiming to monitor the side effects of COVID-19 vaccines following booster doses, and the long-term safety and effectiveness of said vaccines.
Links
MUNI/A/1608/2020, interní kód MUName: Prohlubování znalostí v oblasti zdravotních rizik a benefitů výživy, prostředí a životního stylu III
Investor: Masaryk University
MUNI/IGA/1543/2020, interní kód MUName: Evidence-based Practice of Healthcare Professionals and Students in the Czech Republic (Acronym: Evidence-Based Practice in Czechia)
Investor: Masaryk University
PrintDisplayed: 27/5/2024 19:55